Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113963695 | 11396369 | 5 | F | 20140624 | 20160816 | 20150819 | 20160825 | EXP | US-JNJFOC-20150805123 | JANSSEN | 44.85 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113963695 | 11396369 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 22406 | 20 | MG | TABLET | ||||||
| 113963695 | 11396369 | 7 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 113963695 | 11396369 | 8 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113963695 | 11396369 | 1 | Cardiovascular disorder |
| 113963695 | 11396369 | 2 | Cardiovascular disorder |
| 113963695 | 11396369 | 3 | Cardiovascular disorder |
| 113963695 | 11396369 | 4 | Peripheral arterial occlusive disease |
| 113963695 | 11396369 | 5 | Peripheral arterial occlusive disease |
| 113963695 | 11396369 | 6 | Peripheral arterial occlusive disease |
| 113963695 | 11396369 | 7 | Cerebrovascular accident |
| 113963695 | 11396369 | 8 | Cerebrovascular accident |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113963695 | 11396369 | HO |
| 113963695 | 11396369 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113963695 | 11396369 | Anaemia | |
| 113963695 | 11396369 | Gastrointestinal haemorrhage | |
| 113963695 | 11396369 | Haematemesis | |
| 113963695 | 11396369 | Internal haemorrhage | |
| 113963695 | 11396369 | Off label use | |
| 113963695 | 11396369 | Product use issue | |
| 113963695 | 11396369 | Uterine haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113963695 | 11396369 | 1 | 20150831 | 20160227 | 0 | |
| 113963695 | 11396369 | 2 | 20140807 | 20140906 | 0 | |
| 113963695 | 11396369 | 3 | 20140624 | 20150515 | 0 | |
| 113963695 | 11396369 | 4 | 20140807 | 20140906 | 0 | |
| 113963695 | 11396369 | 5 | 20140624 | 20150515 | 0 | |
| 113963695 | 11396369 | 6 | 20150831 | 20160227 | 0 |